Read the full article by Associate Sabahat Imtiaz and Legal Director Nigel Wood for the implications for MGAs underwriting these risks: #MGA #UnderwritingRisk #CosmeticIVTherapy #ClinicalNegligence #HealthcareInsurance To view or add a comment, sign in Pleased to have contributed to this piece with Nigel Wood on the risks associated with cosmetic IV therapy and the implications for underwriters
Yes since the procedure already involves liposuction to harvest fat from a donor area, many patients choose donor sites (such as the abdomen, thighs or flanks) theyd also like contoured, effectively achieving two goals from one recovery period rather than two separate procedures
GLP-1 receptor agonists are available in both daily and weekly formulations, each offering distinct advantages depending on patient preference, lifestyle, and clinical circumstances
Reduced glutathione (L-glutathione) in the form of S-acetyl glutathione, a stabilised form of glutathione
Healthcare providers should stay updated on emerging treatments, such as novel GLP-1 receptor agonists, combination therapies, and pharmacogenomics-based interventions, to provide the best care to their patients